Related Experiment Video
Updated: Jun 18, 2026

Bacteriophage Removal from Infected Salmonella Cultures
Published on: June 28, 2024
Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy
Rosanna Capparelli1, Nunzia Nocerino, Marco Iannaccone
1Faculty of Biotechnology, University of Naples Federico II, Naples, Italy.
Background:
The most serious criticisms leveled at bacteriophage therapy are as follows: phages induce neutralizing antibodies, phages are active only when administered shortly after bacterial infection, and phage-resistant bacteria emerge rapidly in the course of therapy.
Methods:
Phages lytic for several Salmonella enterica serovars were isolated by means of standard protocols from feces of patients with gastroenteritis. Growth of S. enterica serovar Paratyphi B (Salp572(phi1S)) in the presence of phage phi1 (selected from among 8 phages for its larger host range) provided a phage phi1-resistant bacterial strain (Salp572(phi1R)). The properties of the Salp572(phi1S) and Salp572(phi1R) strains and of phage phi1 were studied in a mouse model of experimental infection.
Results:
Phages induced nonneutralizing antibodies and were active 2 weeks after experimental infection of mice; phage-resistant bacteria were avirulent and short lived in vivo. More importantly, phage-resistant bacteria were excellent vaccines, protecting against lethal doses of heterologous S. enterica serovars.
Conclusions:
Phage therapy effectiveness has not yet been properly assessed.
Insights
Bacteriophage therapy faces criticism, but research shows phages remain active longer than expected. Importantly, phage-resistant bacteria offer potential as vaccines against Salmonella infections.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Bacteriophage therapy is criticized for inducing neutralizing antibodies, limited activity duration, and rapid emergence of resistant bacteria.
- These criticisms pose significant challenges to the clinical application of phage therapy.
Purpose of the Study:
- To investigate the validity of common criticisms against bacteriophage therapy.
- To evaluate the efficacy and host-pathogen dynamics in a mouse model.
Main Methods:
- Isolated phages lytic for Salmonella enterica serovars from human feces.
- Developed a phage-resistant Salmonella strain (Salp572(phi1R)) and compared its properties to the wild-type (Salp572(phi1S)) in a mouse infection model.
- Studied antibody response and bacterial persistence in vivo.
Main Results:
- Phages induced non-neutralizing antibodies and remained active for at least two weeks post-infection in mice.
- Phage-resistant bacteria exhibited reduced virulence and short survival in vivo.
- Crucially, phage-resistant Salmonella strains demonstrated significant potential as vaccines, protecting against lethal challenge with other Salmonella serovars.
Conclusions:
- The study challenges established criticisms of bacteriophage therapy.
- Phage-resistant bacteria may have therapeutic applications, such as vaccine development.
- Further assessment of bacteriophage therapy's effectiveness is warranted.
More Related Videos
07:22Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
08:46T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo
Published on: January 26, 2024
Related Concept Videos
Lytic Cycle of Bacteriophages
Bacteriophages of the Human Virome
Biological Methods for Microbial Control
Lysogenic Cycle of Bacteriophages
DNA Bacteriophages
Viral Replication: Lysogenic Cycle